| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | endopeptidase activity | ADAMTS10 MST1 CASP12 ADAMTS3 ADAMTS1 PIGK TLL1 TLL2 USP29 ADAMTS20 KLK1 F10 USP33 | 4.00e-09 | 430 | 72 | 13 | GO:0004175 |
| GeneOntologyMolecularFunction | peptidase activity | ADAMTS10 MST1 CASP12 ADAMTS3 ADAMTS1 PIGK TLL1 TLL2 USP29 ADAMTS20 MINDY2 KLK1 F10 USP33 | 7.36e-08 | 654 | 72 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 4.70e-06 | 120 | 72 | 6 | GO:0004222 | |
| GeneOntologyMolecularFunction | histone phosphatase activity | 3.84e-05 | 3 | 72 | 2 | GO:0140789 | |
| GeneOntologyMolecularFunction | histone H2AXY142 phosphatase activity | 3.84e-05 | 3 | 72 | 2 | GO:0140793 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 8.45e-05 | 200 | 72 | 6 | GO:0008237 | |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 2.64e-04 | 86 | 72 | 4 | GO:0004197 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 6.18e-04 | 190 | 72 | 5 | GO:0004252 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 6.48e-04 | 192 | 72 | 5 | GO:0008234 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 9.09e-04 | 207 | 72 | 5 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 1.01e-03 | 212 | 72 | 5 | GO:0017171 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 4.51e-05 | 377 | 71 | 8 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 4.59e-05 | 378 | 71 | 8 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 4.68e-05 | 379 | 71 | 8 | GO:0045229 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.37e-04 | 76 | 71 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | protein K48-linked deubiquitination | 1.64e-04 | 31 | 71 | 3 | GO:0071108 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS10 MST1 ADAMTS3 ADAMTS1 MUC17 GLG1 ACAN ADAMTS20 PAPLN | 3.67e-04 | 656 | 71 | 9 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS10 MST1 ADAMTS3 ADAMTS1 MUC17 GLG1 ACAN ADAMTS20 PAPLN | 3.75e-04 | 658 | 71 | 9 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.24e-04 | 530 | 71 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | Golgi lumen | 5.19e-04 | 109 | 71 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 9.15e-04 | 56 | 71 | 3 | GO:0008023 | |
| Domain | ADAM_spacer1 | 1.90e-08 | 23 | 69 | 5 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.90e-08 | 23 | 69 | 5 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.39e-08 | 24 | 69 | 5 | IPR013273 | |
| Domain | MetalloPept_cat_dom | 5.32e-07 | 81 | 69 | 6 | IPR024079 | |
| Domain | - | 5.32e-07 | 81 | 69 | 6 | 3.40.390.10 | |
| Domain | ZINC_PROTEASE | 1.64e-06 | 98 | 69 | 6 | PS00142 | |
| Domain | TSP_1 | 3.54e-06 | 63 | 69 | 5 | PF00090 | |
| Domain | TSP1 | 4.13e-06 | 65 | 69 | 5 | SM00209 | |
| Domain | TSP1_rpt | 4.13e-06 | 65 | 69 | 5 | IPR000884 | |
| Domain | TSP1 | 4.13e-06 | 65 | 69 | 5 | PS50092 | |
| Domain | Peptidase_M12B_N | 1.27e-05 | 39 | 69 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.27e-05 | 39 | 69 | 4 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.41e-05 | 40 | 69 | 4 | PS00427 | |
| Domain | Reprolysin | 1.41e-05 | 40 | 69 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 1.41e-05 | 40 | 69 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.41e-05 | 40 | 69 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 1.41e-05 | 40 | 69 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 1.56e-05 | 41 | 69 | 4 | IPR001762 | |
| Domain | BMP_1/tolloid-like | 4.03e-05 | 3 | 69 | 2 | IPR015446 | |
| Domain | PLAC | 4.48e-05 | 19 | 69 | 3 | PS50900 | |
| Domain | PLAC | 4.48e-05 | 19 | 69 | 3 | IPR010909 | |
| Domain | EYA_fam | 8.03e-05 | 4 | 69 | 2 | IPR028472 | |
| Domain | EYA_dom | 8.03e-05 | 4 | 69 | 2 | IPR006545 | |
| Domain | Peptidase_M12A | 2.00e-04 | 6 | 69 | 2 | IPR001506 | |
| Domain | Astacin | 2.00e-04 | 6 | 69 | 2 | PF01400 | |
| Domain | PLAC | 1.19e-03 | 14 | 69 | 2 | PF08686 | |
| Domain | Spectrin | 3.24e-03 | 23 | 69 | 2 | PF00435 | |
| Domain | VWC | 4.78e-03 | 28 | 69 | 2 | PF00093 | |
| Domain | PH_dom-like | 4.86e-03 | 426 | 69 | 6 | IPR011993 | |
| Domain | ZnMc | 5.12e-03 | 29 | 69 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 5.12e-03 | 29 | 69 | 2 | IPR006026 | |
| Domain | Spectrin_repeat | 5.12e-03 | 29 | 69 | 2 | IPR002017 | |
| Domain | EGF_Ca-bd_CS | 5.55e-03 | 97 | 69 | 3 | IPR018097 | |
| Domain | EGF_CA | 5.88e-03 | 99 | 69 | 3 | PS01187 | |
| Domain | zf-C2H2_6 | 6.08e-03 | 314 | 69 | 5 | PF13912 | |
| Domain | Spectrin/alpha-actinin | 6.21e-03 | 32 | 69 | 2 | IPR018159 | |
| Domain | SPEC | 6.21e-03 | 32 | 69 | 2 | SM00150 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.10e-03 | 106 | 69 | 3 | IPR000152 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.64e-06 | 68 | 49 | 5 | M27303 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 9.58e-06 | 143 | 49 | 6 | M27275 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.69e-06 | 39 | 49 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 9.69e-06 | 39 | 49 | 4 | MM15165 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.67e-05 | 109 | 49 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.00e-05 | 111 | 49 | 5 | M27416 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS10 FGF23 KLHL5 RNF123 ADAMTS3 ADAMTS1 MUC17 PIGK SPTAN1 USP29 ADAMTS20 CLSPN F10 USP33 | 1.87e-04 | 1389 | 49 | 14 | MM15307 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 2.16e-04 | 250 | 49 | 6 | M27554 | |
| Pubmed | TARS3 RNF123 WARS1 ZNF473 ADAMTS1 CIAO3 SUPT5H SYNE1 SPTAN1 SPRED1 EYA3 CBR3 USP33 ZNF292 ZNF662 | 7.09e-08 | 1285 | 74 | 15 | 35914814 | |
| Pubmed | 5.84e-07 | 75 | 74 | 5 | 20637190 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 2.01e-06 | 12 | 74 | 3 | 25770910 | |
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 4.13e-06 | 15 | 74 | 3 | 38871984 | |
| Pubmed | USP29 controls the stability of checkpoint adaptor Claspin by deubiquitination. | 4.47e-06 | 2 | 74 | 2 | 24632611 | |
| Pubmed | Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome. | 4.47e-06 | 2 | 74 | 2 | 28417352 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 11313359 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 19351884 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 9020840 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 10516436 | ||
| Pubmed | Eyes absent represents a class of protein tyrosine phosphatases. | 1.34e-05 | 3 | 74 | 2 | 14628052 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 18824173 | ||
| Pubmed | Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival. | 2.67e-05 | 4 | 74 | 2 | 28796414 | |
| Pubmed | Mammalian tolloid proteinases: role in growth factor signalling. | 2.67e-05 | 4 | 74 | 2 | 27391803 | |
| Pubmed | ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats. | 2.67e-05 | 4 | 74 | 2 | 10094461 | |
| Pubmed | Misexpression of the eyes absent family triggers the apoptotic program. | 2.67e-05 | 4 | 74 | 2 | 11700312 | |
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 21584905 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 9195991 | ||
| Pubmed | Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. | 4.45e-05 | 5 | 74 | 2 | 16061471 | |
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 11831030 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 9006082 | ||
| Pubmed | 4.45e-05 | 5 | 74 | 2 | 10479448 | ||
| Pubmed | Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. | 4.45e-05 | 5 | 74 | 2 | 10490620 | |
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 31366218 | ||
| Pubmed | EYA4, a novel vertebrate gene related to Drosophila eyes absent. | 6.66e-05 | 6 | 74 | 2 | 9887327 | |
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 12054629 | ||
| Pubmed | 7.26e-05 | 650 | 74 | 8 | 38777146 | ||
| Pubmed | Association of gene polymorphisms with chronic kidney disease in Japanese individuals. | 8.00e-05 | 39 | 74 | 3 | 19724895 | |
| Pubmed | 9.31e-05 | 7 | 74 | 2 | 21148564 | ||
| Pubmed | Cloning and characterization of two vertebrate homologs of the Drosophila eyes absent gene. | 9.31e-05 | 7 | 74 | 2 | 9049631 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 1.24e-04 | 8 | 74 | 2 | 12634303 | |
| Pubmed | 1.59e-04 | 9 | 74 | 2 | 23829686 | ||
| Pubmed | 1.99e-04 | 10 | 74 | 2 | 11167130 | ||
| Pubmed | 2.43e-04 | 11 | 74 | 2 | 33909046 | ||
| Pubmed | 2.43e-04 | 11 | 74 | 2 | 38750698 | ||
| Pubmed | 2.83e-04 | 1007 | 74 | 9 | 34597346 | ||
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 3.03e-04 | 150 | 74 | 4 | 22678362 | |
| Pubmed | 3.43e-04 | 13 | 74 | 2 | 32909945 | ||
| Pubmed | A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. | 3.43e-04 | 13 | 74 | 2 | 11586298 | |
| Pubmed | 3.51e-04 | 64 | 74 | 3 | 22261194 | ||
| Pubmed | 3.56e-04 | 284 | 74 | 5 | 29459677 | ||
| Pubmed | 4.61e-04 | 15 | 74 | 2 | 24469813 | ||
| Pubmed | 5.26e-04 | 16 | 74 | 2 | 30579834 | ||
| Pubmed | Association analysis of 3p21 with Crohn's disease in a New Zealand population. | 5.95e-04 | 17 | 74 | 2 | 20307617 | |
| Pubmed | 5.95e-04 | 17 | 74 | 2 | 10464288 | ||
| Pubmed | 5.95e-04 | 17 | 74 | 2 | 22183742 | ||
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 6.68e-04 | 18 | 74 | 2 | 35503090 | |
| Pubmed | 7.94e-04 | 513 | 74 | 6 | 25798074 | ||
| Pubmed | 8.28e-04 | 20 | 74 | 2 | 19922873 | ||
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 8.59e-04 | 198 | 74 | 4 | 20881960 | |
| Pubmed | 9.51e-04 | 733 | 74 | 7 | 34672954 | ||
| Pubmed | 1.00e-03 | 22 | 74 | 2 | 14627618 | ||
| Pubmed | 1.20e-03 | 24 | 74 | 2 | 29791855 | ||
| Pubmed | Essential pro-Bmp roles of crossveinless 2 in mouse organogenesis. | 1.30e-03 | 25 | 74 | 2 | 17035289 | |
| Pubmed | 1.30e-03 | 25 | 74 | 2 | 29475039 | ||
| Pubmed | 1.34e-03 | 568 | 74 | 6 | 37774976 | ||
| Pubmed | Dachshund homologues play a conserved role in islet cell development. | 1.51e-03 | 27 | 74 | 2 | 20869363 | |
| Pubmed | 1.75e-03 | 29 | 74 | 2 | 23843306 | ||
| Pubmed | 2.12e-03 | 1084 | 74 | 8 | 11544199 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.27e-04 | 1192 | 74 | 9 | chr19q13 | |
| Cytoband | 19q13.41 | 2.80e-04 | 78 | 74 | 3 | 19q13.41 | |
| Cytoband | 2q33.2 | 3.86e-04 | 18 | 74 | 2 | 2q33.2 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.47e-07 | 19 | 53 | 4 | 50 | |
| GeneFamily | EYA transcriptional coactivator and phosphatases | 5.04e-05 | 4 | 53 | 2 | 1044 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 1.26e-04 | 6 | 53 | 2 | 894 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.08e-03 | 718 | 53 | 8 | 28 | |
| Coexpression | NABA_MATRISOME | ADAMTS10 MST1 FGF23 ADAMTS3 ADAMTS1 MUC17 PXDNL ACAN TLL1 TLL2 KCP ADAMTS20 PAPLN F10 | 9.26e-07 | 1026 | 74 | 14 | M5889 |
| Coexpression | NABA_MATRISOME | ADAMTS10 MST1 FGF23 ADAMTS3 ADAMTS1 MUC17 ACAN TLL1 TLL2 KCP ADAMTS20 PAPLN F10 | 4.42e-06 | 1008 | 74 | 13 | MM17056 |
| Coexpression | NABA_ECM_REGULATORS | 5.00e-06 | 238 | 74 | 7 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 5.58e-06 | 242 | 74 | 7 | MM17062 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS10 MST1 FGF23 ADAMTS3 ADAMTS1 MUC17 TLL1 TLL2 ADAMTS20 F10 | 4.17e-05 | 738 | 74 | 10 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS10 MST1 FGF23 ADAMTS3 ADAMTS1 MUC17 TLL1 TLL2 ADAMTS20 F10 | 4.82e-05 | 751 | 74 | 10 | M5885 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.64e-07 | 194 | 74 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.03e-06 | 200 | 74 | 6 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.03e-06 | 200 | 74 | 6 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-06 | 150 | 74 | 5 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 183 | 74 | 5 | d67454baf0cf791a743b51afd1cb25bfb5765385 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-05 | 183 | 74 | 5 | e49ac8314b6fe98426b1514ea68d646297b8bc0f | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-05 | 190 | 74 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-05 | 191 | 74 | 5 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-05 | 194 | 74 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type | 1.79e-05 | 194 | 74 | 5 | 36afc4e48d267be3b8aa1e33fad043bcd54c6bc5 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 1.84e-05 | 195 | 74 | 5 | e91e7f89163c615b706f3297b641b1e4c966f5e6 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 1.84e-05 | 195 | 74 | 5 | a5a10ef9254c266316e5591bec19e159cc3caead | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.02e-05 | 199 | 74 | 5 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.02e-05 | 199 | 74 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.02e-05 | 199 | 74 | 5 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 74 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 74 | 5 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.07e-05 | 200 | 74 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 74 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-NK|Leuk-UTI / Disease, condition lineage and cell class | 2.07e-05 | 200 | 74 | 5 | bb37fed4872e71f413ae7c4aa12586fa31075334 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.07e-05 | 200 | 74 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.05e-04 | 147 | 74 | 4 | 27e97a7b1dc296f52990b5810a52ab0a7ef2b9e6 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 159 | 74 | 4 | 95128a2367ff2a639b21913c0350924c174faef8 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 162 | 74 | 4 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 162 | 74 | 4 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.72e-04 | 167 | 74 | 4 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 168 | 74 | 4 | 9e7b4b9b977e90e083f5164013e79df8bc2d492e | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 168 | 74 | 4 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_T-T_NK-Treg|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.76e-04 | 168 | 74 | 4 | 99117480687e2b8e7521d3ae9e020791757ec48e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue | 1.88e-04 | 171 | 74 | 4 | 1ee505b91f15191d294a5d491ecdf154c08b8622 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 171 | 74 | 4 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 171 | 74 | 4 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.93e-04 | 172 | 74 | 4 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 173 | 74 | 4 | 3d7c281a1a9f183a5a861d1a9c7b50d216535893 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 173 | 74 | 4 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 173 | 74 | 4 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 173 | 74 | 4 | 3aa90578371039f81b7c6fa873ec70f8f2bc7dfa | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-04 | 174 | 74 | 4 | 778e0317c0c63fa4efd74114feb760975b819d92 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.15e-04 | 177 | 74 | 4 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.15e-04 | 177 | 74 | 4 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 2.15e-04 | 177 | 74 | 4 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.15e-04 | 177 | 74 | 4 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.15e-04 | 177 | 74 | 4 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 178 | 74 | 4 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK-NK_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.20e-04 | 178 | 74 | 4 | a34bb693b72684cbd97ac9efff77d2d14e41be75 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-04 | 179 | 74 | 4 | ec69e1dd897414033ba5b007aa82655a79adca6c | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.24e-04 | 179 | 74 | 4 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-04 | 180 | 74 | 4 | eb5a57604c7f2ad256c300085dbf5069d0ae1ad0 | |
| ToppCell | 368C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-04 | 180 | 74 | 4 | ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 180 | 74 | 4 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.34e-04 | 181 | 74 | 4 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.39e-04 | 182 | 74 | 4 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-04 | 183 | 74 | 4 | 7961e05c6e9964da159059c6bfb4f7e7e14308c2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-04 | 184 | 74 | 4 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-04 | 184 | 74 | 4 | 603faafb7b289a3c0242c84fc800c050c8a092ea | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-04 | 184 | 74 | 4 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-04 | 184 | 74 | 4 | c350504bfe0ec31cd2fc2199de9b5fff151a8c5e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-04 | 184 | 74 | 4 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-04 | 185 | 74 | 4 | ae53aa2ecfe418a5dbd7d963a995bc06dab94f56 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 186 | 74 | 4 | 799903b68bc6f6205d004b44c603424b0d5f7c32 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.60e-04 | 186 | 74 | 4 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.60e-04 | 186 | 74 | 4 | 165d02be3b3eaeb8784a2b0b2020928b21a19bc7 | |
| ToppCell | ASK440-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.60e-04 | 186 | 74 | 4 | ce8e63057a99afa0a9cbf27ae7f9a70c0e972b6d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.65e-04 | 187 | 74 | 4 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.65e-04 | 187 | 74 | 4 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 2.70e-04 | 188 | 74 | 4 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.70e-04 | 188 | 74 | 4 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.81e-04 | 190 | 74 | 4 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 190 | 74 | 4 | e64b191f928935484e2c993d7f8af0572a617a3a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 191 | 74 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-04 | 191 | 74 | 4 | 72f1ddc09080dbfea8d51294cbf7f9d4925f9cc0 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.87e-04 | 191 | 74 | 4 | 6e7f589efc997f32175e0789c5ea7ca46e1389b8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 191 | 74 | 4 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-neuroendocrine_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 191 | 74 | 4 | 3ce403e0beedb544edeb3ae6eb30267040d00c21 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-04 | 191 | 74 | 4 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-04 | 192 | 74 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | Pericytes|World / lung cells shred on cell class, cell subclass, sample id | 2.93e-04 | 192 | 74 | 4 | 057ad22b878c0c5fb59ed1412ca13db945c57a5a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-04 | 192 | 74 | 4 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-04 | 193 | 74 | 4 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-04 | 193 | 74 | 4 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.99e-04 | 193 | 74 | 4 | 9104b572d9c3c99080e4b7455993fbb944bf117d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-04 | 193 | 74 | 4 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.05e-04 | 194 | 74 | 4 | a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.05e-04 | 194 | 74 | 4 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.05e-04 | 194 | 74 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.05e-04 | 194 | 74 | 4 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.05e-04 | 194 | 74 | 4 | 0abca32c3547a45cebab0bd69c1f7a0002deaa80 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.05e-04 | 194 | 74 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | T_cells-CD56_dim_CD16+_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.05e-04 | 194 | 74 | 4 | 335c6c2f3f319d4f19eace62f8826a0f40c130f6 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 3.11e-04 | 195 | 74 | 4 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.11e-04 | 195 | 74 | 4 | 7155cc12cc6a97efd626bbdb95249fb3d7041dcf | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.11e-04 | 195 | 74 | 4 | a52ee3ad6cd317f10b9308450517861ef2e363bb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.11e-04 | 195 | 74 | 4 | b3660779f274ca97dd844cf83f62d85ba88cb182 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 3.11e-04 | 195 | 74 | 4 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.11e-04 | 195 | 74 | 4 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.11e-04 | 195 | 74 | 4 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.17e-04 | 196 | 74 | 4 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.17e-04 | 196 | 74 | 4 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-NK_CD16|Liver / Manually curated celltypes from each tissue | 3.17e-04 | 196 | 74 | 4 | e6d4853ccefbcd45a019cee595811f0474dcc036 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.17e-04 | 196 | 74 | 4 | 8c25fa61c117a60ddd4cbd2f95ae5b66f986a1ec | |
| Disease | eye disease (implicated_via_orthology) | 9.00e-05 | 6 | 73 | 2 | DOID:5614 (implicated_via_orthology) | |
| Disease | body composition measurement | 1.19e-04 | 193 | 73 | 5 | EFO_0005106 | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 1.26e-04 | 7 | 73 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 1.26e-04 | 7 | 73 | 2 | EFO_0020797 | |
| Disease | dental caries | 1.21e-03 | 187 | 73 | 4 | EFO_0003819 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QELCGVEDDFHNQFA | 6 | Q8WVB6 | |
| FANEDFSCHGDLNTD | 721 | Q8IVF6 | |
| DRFDNCVTFTNLHGD | 1111 | Q7Z2Y8 | |
| GDLDHFSNSDNCREV | 381 | O96018 | |
| ANEDFSCHGDLNTDQ | 731 | A2A2Z9 | |
| LHDDTIFEIFNNRNC | 191 | Q6UXS9 | |
| QAYDADEQCRFQHGV | 471 | Q9H324 | |
| NFGHRLADNECQELS | 996 | P59510 | |
| DDFGTEHEQINGQCS | 356 | Q9NZN5 | |
| QLQSGRFDCADRQFH | 2121 | Q6ZS30 | |
| NNGKTFREEQCEAHN | 616 | Q9UHI8 | |
| ADTHLFFNDLEECDQ | 351 | Q99504 | |
| GTRNFQDFDCQEHDI | 21 | Q9UGV2 | |
| ESRHFQIDYDEDGNC | 1851 | Q15746 | |
| GRHNLFDDENTAQFV | 76 | P06870 | |
| SRFNEDRDFQGNHFD | 6 | Q9UKJ3 | |
| EAQFGDFHNTAQCII | 731 | Q9ULD0 | |
| NGDETAVEDFCNNFR | 146 | Q9Y4A0 | |
| CTSDEFFQALNHAEQ | 191 | Q96PQ7 | |
| EDQAEQFFRSGHTNN | 31 | Q92643 | |
| GDRCGHQENVEDQNE | 451 | Q9NYA4 | |
| EQLQAAYEDGFHQCD | 186 | P16112 | |
| HCQEEIGSRNFFERD | 386 | P49023 | |
| DRAAQHDQGQYECQA | 476 | A1KZ92 | |
| QNFCHDVADNQIDSG | 701 | Q92896 | |
| NTEECQKHFEDFRAQ | 601 | O15072 | |
| NCSSDHVFNENGNLE | 291 | Q9Y2F5 | |
| QRHAELQQCEFLGDE | 246 | Q96BT1 | |
| NSDCFQEEDLRQGFQ | 76 | Q96Q40 | |
| QNNGRFNFHRGCEAD | 181 | Q8TBM8 | |
| NHPEDSEFRNQAECI | 261 | Q5T0N1 | |
| ENCRFQHQTLENGYD | 111 | Q9GZV9 | |
| FRENCGLNDHGDFVT | 56 | Q9H665 | |
| NFEENAENCRGHSSR | 331 | Q8NA82 | |
| AFENCSEDLQERFHS | 146 | O75828 | |
| RHCDEVGFNAEEAHN | 6 | P51808 | |
| GNDDCRIHIFAQQND | 181 | Q6IA86 | |
| HAQLEENFCRNPDGD | 411 | P26927 | |
| LDNGDCDQFCHEEQN | 131 | P00742 | |
| REANGQGHFQERSFC | 396 | Q9H6A0 | |
| QNIGFDICQDDDSIH | 4446 | Q685J3 | |
| ADTHLFFNDLEDCDQ | 316 | O00167 | |
| QEGELCVFFRNNHFS | 436 | Q8NBR6 | |
| RFQQDDAHIFCTVEQ | 536 | A2RTX5 | |
| RDTIEEHRQFGGNCD | 381 | P23381 | |
| DNELSNVEFHCGRAE | 476 | Q8IZ69 | |
| GLTFQSFEIERHDNC | 501 | O43897 | |
| QDCASELGSFEDQHR | 2511 | Q8NF91 | |
| HCGFNNRAQGEEQEA | 196 | Q6P9H5 | |
| SCLSQGREHQDGEEF | 901 | Q6ZWJ8 | |
| REHNFQPGDNVEVCE | 416 | O00267 | |
| ATDFQGNDFDNDHNR | 76 | Q16384 | |
| PDFFNQEHQTRDVDC | 256 | Q9H6Q4 | |
| ESNFLGNNHSEECQV | 431 | Q9HAW4 | |
| RLENEHLNNCGEFRA | 611 | Q9UBH6 | |
| FRAEQCAEFDGAEFQ | 86 | O95428 | |
| CRFNQEEGVGDTHNS | 156 | Q5XPI4 | |
| ARQFQDAGHFDAENI | 741 | Q13813 | |
| RFNHEENVRGKCQDA | 341 | Q7Z699 | |
| FQERKEQDCFNDAHV | 986 | O60281 | |
| LTFNEFEIEQHQECA | 816 | Q9Y6L7 | |
| FQRDCGDASQEQHQR | 606 | Q9HBJ7 | |
| HNIEFQCQEDERNGH | 111 | Q8N4W9 | |
| QRFEDLTTHRCDFQG | 176 | Q658L1 | |
| CEGREDGLQHANQYE | 2056 | Q86YA3 | |
| HDIEFQCQEDERNGL | 111 | Q8N823 | |
| NFLCEDDQFEHQASC | 151 | Q9Y3S2 | |
| DDQFEHQASCQVLEA | 156 | Q9Y3S2 | |
| TECGQDFAQEAGLHQ | 146 | Q9H609 | |
| IHDIEFQCQEDERNG | 41 | Q6ZNG1 | |
| QQQVAACEGRAFDNE | 366 | Q96SA4 | |
| ENENGSRCFSEDNNE | 331 | Q8TEY7 | |
| ECGKCFDQNEDFDQH | 196 | Q6ZS27 | |
| PTVHQECEQGFDRNA | 236 | Q8WTR7 | |
| DRGDAFDFNVALQDH | 111 | Q9NVZ3 |